Majically, the Board has now found $20m in annualised savings to be extracted in Pathology; it took a a few slaps, in loss of bowel screening contract and wages reset cost increase, for them to come to their senses.
Knife to costs has been argued here as essential for well over 24 months.
Afraid too little, too late.
Ann: Presentation of Half Year Results, page-2
-
- There are more pages in this discussion • 18 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add HLS (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.35 |
Change
0.033(2.47%) |
Mkt cap ! $1.212B | |||
| Open | High | Low | Value | Volume |
| $1.35 | $1.36 | $1.33 | $504.9K | 377.1K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 7 | 1588 | $1.35 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.35 | 19582 | 17 |
View Market Depth
| Last trade - 11.20am 22/11/2024 (20 minute delay) ? |
| HLS (ASX) Chart |
